Clinical Trial Update: VXM01 Plus Avelumab Combination Study in Progressive Glioblastoma [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on the combination of VXM01 with avelumab in recurrent glioblastoma across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Avelumab (avelumab)
• VXM01

Snippet

Sponsor: Vaximm GmbH | Conditions: Recurrent Glioblastoma | Phase 1, Phase 2 | Status: UNKNOWN